메뉴 건너뛰기




Volumn 27, Issue 13, 2006, Pages 1558-1564

International variation in invasive care of the elderly with acute coronary syndromes

Author keywords

Acute coronary syndromes; Cardiac catheterization; Elderly; International comparisons

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEALTH CARE UTILIZATION; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 33745461617     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl067     Document Type: Article
Times cited : (31)

References (25)
  • 1
    • 0038681261 scopus 로고    scopus 로고
    • Cardiac procedure use and outcomes in elderly patients with acute myocardial infarction in the United States and Quebec, Canada, 1988 to 1994
    • Pilote L, Saynina O, Lavoie F, McClellan M. Cardiac procedure use and outcomes in elderly patients with acute myocardial infarction in the United States and Quebec, Canada, 1988 to 1994. Med Care 2003;41:813-822.
    • (2003) Med Care , vol.41 , pp. 813-822
    • Pilote, L.1    Saynina, O.2    Lavoie, F.3    McClellan, M.4
  • 5
    • 0032811508 scopus 로고    scopus 로고
    • Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban vs. aspirin to Yield Maximum Protection from ischaemic Heart events post-acute cOroNary sYndromes (SYMPHONY) trial
    • Newby LK, for the SYMPHONY Steering Committee. Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the Sibrafiban vs. aspirin to Yield Maximum Protection from ischaemic Heart events post-acute cOroNary sYndromes (SYMPHONY) trial. Am Heart J 1999;138:210-218.
    • (1999) Am Heart J , vol.138 , pp. 210-218
    • Newby, L.K.1
  • 6
    • 0034728088 scopus 로고    scopus 로고
    • Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes; a randomized trial
    • The SYMPHONY Investigators. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes; a randomized trial. Lancet 2000;355:337-345.
    • (2000) Lancet , vol.355 , pp. 337-345
  • 7
    • 0035799340 scopus 로고    scopus 로고
    • Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes
    • Second SYMPHONY Investigators. Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes. Circulation 2001;103:1727-1733.
    • (2001) Circulation , vol.103 , pp. 1727-1733
  • 11
    • 0027478379 scopus 로고
    • Comparative case fatality analysis of the international tissue plasminogen activator/streptokinase mortality trial: Variation by country beyond predictive profile
    • Barbash GI, White HD, Goldbourt U, White HD, Van de Werf F. Comparative case fatality analysis of the international tissue plasminogen activator/streptokinase mortality trial: variation by country beyond predictive profile. J Am Coll Cardiol 1993;21:281-286.
    • (1993) J Am Coll Cardiol , vol.21 , pp. 281-286
    • Barbash, G.I.1    White, H.D.2    Goldbourt, U.3    White, H.D.4    Van De Werf, F.5
  • 12
    • 0029318939 scopus 로고
    • Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial
    • Pilote L, Granger C, Armstrong PW, Mark DB, Hlatky MA. Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Med Care 1995;33:598-610.
    • (1995) Med Care , vol.33 , pp. 598-610
    • Pilote, L.1    Granger, C.2    Armstrong, P.W.3    Mark, D.B.4    Hlatky, M.A.5
  • 13
    • 0034687113 scopus 로고    scopus 로고
    • Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: 1 Year follow-up of patients without ST-segment elevation
    • Fu Y, Chang W, Mark D, Califf RM, Mackenzie B, Granger CB, Topol EJ, Hlatky M, Armstrong PW, for the GUSTO IIb Investigators. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: 1 year follow-up of patients without ST-segment elevation. Circulation 2000;102:1375-1381.
    • (2000) Circulation , vol.102 , pp. 1375-1381
    • Fu, Y.1    Chang, W.2    Mark, D.3    Califf, R.M.4    Mackenzie, B.5    Granger, C.B.6    Topol, E.J.7    Hlatky, M.8    Armstrong, P.W.9
  • 17
    • 0035827865 scopus 로고    scopus 로고
    • The elderly and women: Are they adequately represented in randomized trials of acute coronary syndromes?
    • Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. The elderly and women: are they adequately represented in randomized trials of acute coronary syndromes? JAMA 2001;286:708-713.
    • (2001) JAMA , vol.286 , pp. 708-713
    • Lee, P.Y.1    Alexander, K.P.2    Hammill, B.G.3    Pasquali, S.K.4    Peterson, E.D.5
  • 18
    • 0033612951 scopus 로고    scopus 로고
    • Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multi-center study
    • FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multi-center study. Lancet 1999;354:708-715.
    • (1999) Lancet , vol.354 , pp. 708-715
  • 19
    • 0037036961 scopus 로고    scopus 로고
    • Interventional vs. conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomized trial
    • Fox KAA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ, for the RITA Investigators. Interventional vs. conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Lancet 2002;360:743-751.
    • (2002) Lancet , vol.360 , pp. 743-751
    • Fox, K.A.A.1    Poole-Wilson, P.A.2    Henderson, R.A.3    Clayton, T.C.4    Chamberlain, D.A.5    Shaw, T.R.6    Wheatley, D.J.7    Pocock, S.J.8
  • 22


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.